Has the market price of Mobotinib (Mobosetinib) changed recently?

Mobocertinib (also known as Mobocertinib) is an oral targeted drug mainly used to treat EGFR Exon20 insertion mutation non-small cell lung cancer. Currently, Mobotinib has been approved for marketing in my country, but as it has not yet been included in the national medical insurance directory, patients’ channels for directly purchasing the drug in China are relatively limited. Patients who want to obtain Mobotinib usually need to consult the specific supply situation through professional hospital pharmacies, or consider purchasing the drug overseas.

From a price point of view, Mobotinib has two options: original drug and generic drug in overseas markets. The original drug is mainly divided into the Hong Kong version of China and the version produced by Japan's Takeda Pharmaceutical. The current price per box is approximately RMB 7,000 to RMB 8,000. Due to factors such as different supply locations and exchange rate fluctuations, the specific price may vary slightly in various regions. Overall, the price is still at a relatively high level, which is a considerable financial burden for some patients.

In order to meet the medication needs of different patients, generic drugs of Mobotinib have also been launched in overseas markets. Take the imitation version produced in Laos as an example. The specifications and ingredients are basically the same as the original drug, but the price is more affordable. Each box only costs about 3,000 yuan, which is about half cheaper than the original drug. This provides an affordable option for many patients who wish to take long-term medication to control their conditions, greatly reducing the pressure on treatment costs.

Overall, the price of Mobotinib, whether it is the original drug or a generic drug, has generally remained stable recently without significant fluctuations. However, the selling prices of drugs from different channels and different batches may vary. Patients should choose formal channels when purchasing drugs to ensure drug quality and safety, and use drugs rationally under the guidance of professional doctors to obtain the best therapeutic effect.

References：https://en.wikipedia.org/wiki/Mobocertinib